In this context, previous studies from our group have documented the roles of two histone methyltransferases (HMTs), EZH2 (enhancer of Zeste 2) and G9a/EHMT2 (euchromatic histone-lysine N-methyltransferase 2), in CCA [13–15]. This evidence concerns the gene EHMT2 and cholangiocarcinoma.